FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570233631> ?p ?o ?g. }

• W1570233631 endingPage "2131" @default.
• W1570233631 startingPage "2128" @default.
• W1570233631 abstract "BACKGROUND Imatinib inhibits the c-kit tyrosine kinase, which, accounts for its activity in gastrointestinal stromal tumors. The presence of c-kit protein expression in small cell lung carcinoma (SCLC) tumor specimens, as well as in vitro data supporting the role of c-kit in autocrine and paracrine growth stimulation specifically in SCLC, provided a rationale for studying imatinib in this disease. The authors conducted a Phase II single-institution study of imatinib in patients with recurrent SCLC whose tumor specimens expressed c-kit protein. METHODS Patients with progressive SCLC after one or two previous chemotherapy regimens consented to have their tumor specimens screened by immunoperoxidase stain (CD117, Dako Corporation, Carpinteria, CA) for c-kit protein expression. If present, individuals were then eligible for treatment with an imatinib dose of 400 mg orally twice daily (total, 800 mg per day). RESULTS The presence of c-kit protein was assessable in 36 of 39 (92%) tumor samples. Twenty-eight (78%) tumor samples had immunohistochemical staining for c-kit protein. Twelve patients were enrolled in the treatment portion of the current study. No responses were observed, and all patients had disease progression by Week 4. Edema, fatigue, nausea, and electrolyte abnormalities were the primary toxicities. CONCLUSIONS Imatinib did not have antitumor activity against SCLC, even with c-kit protein present in tumor specimens. The dismal prognosis for these patients with progressive SCLC emphasized the urgent need for continued studies of new therapies in this population. Cancer 2005. © 2005 American Cancer Society." @default.
• W1570233631 created "2016-06-24" @default.
• W1570233631 creator A5003980612 @default.
• W1570233631 creator A5012122212 @default.
• W1570233631 creator A5030558667 @default.
• W1570233631 creator A5035120516 @default.
• W1570233631 creator A5039791495 @default.
• W1570233631 creator A5050489521 @default.
• W1570233631 creator A5052336062 @default.
• W1570233631 creator A5060929583 @default.
• W1570233631 creator A5066086352 @default.
• W1570233631 creator A5075877134 @default.
• W1570233631 creator A5078867875 @default.
• W1570233631 date "2005-01-01" @default.
• W1570233631 modified "2023-10-10" @default.
• W1570233631 title "Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein" @default.
• W1570233631 cites W1932169383 @default.
• W1570233631 cites W2015015957 @default.
• W1570233631 cites W2038110873 @default.
• W1570233631 cites W2077853236 @default.
• W1570233631 cites W2097457793 @default.
• W1570233631 cites W2112237195 @default.
• W1570233631 cites W2134094496 @default.
• W1570233631 cites W2142858515 @default.
• W1570233631 cites W2150501295 @default.
• W1570233631 cites W2328017321 @default.
• W1570233631 cites W4241370600 @default.
• W1570233631 doi "https://doi.org/10.1002/cncr.21000" @default.
• W1570233631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15812822" @default.
• W1570233631 hasPublicationYear "2005" @default.
• W1570233631 type Work @default.
• W1570233631 sameAs 1570233631 @default.
• W1570233631 citedByCount "147" @default.
• W1570233631 countsByYear W15702336312012 @default.
• W1570233631 countsByYear W15702336312013 @default.
• W1570233631 countsByYear W15702336312014 @default.
• W1570233631 countsByYear W15702336312015 @default.
• W1570233631 countsByYear W15702336312016 @default.
• W1570233631 countsByYear W15702336312017 @default.
• W1570233631 countsByYear W15702336312018 @default.
• W1570233631 countsByYear W15702336312020 @default.
• W1570233631 countsByYear W15702336312021 @default.
• W1570233631 countsByYear W15702336312022 @default.
• W1570233631 countsByYear W15702336312023 @default.
• W1570233631 crossrefType "journal-article" @default.
• W1570233631 hasAuthorship W1570233631A5003980612 @default.
• W1570233631 hasAuthorship W1570233631A5012122212 @default.
• W1570233631 hasAuthorship W1570233631A5030558667 @default.
• W1570233631 hasAuthorship W1570233631A5035120516 @default.
• W1570233631 hasAuthorship W1570233631A5039791495 @default.
• W1570233631 hasAuthorship W1570233631A5050489521 @default.
• W1570233631 hasAuthorship W1570233631A5052336062 @default.
• W1570233631 hasAuthorship W1570233631A5060929583 @default.
• W1570233631 hasAuthorship W1570233631A5066086352 @default.
• W1570233631 hasAuthorship W1570233631A5075877134 @default.
• W1570233631 hasAuthorship W1570233631A5078867875 @default.
• W1570233631 hasBestOaLocation W15702336311 @default.
• W1570233631 hasConcept C10205521 @default.
• W1570233631 hasConcept C121608353 @default.
• W1570233631 hasConcept C126322002 @default.
• W1570233631 hasConcept C142724271 @default.
• W1570233631 hasConcept C143998085 @default.
• W1570233631 hasConcept C2776256026 @default.
• W1570233631 hasConcept C2776839831 @default.
• W1570233631 hasConcept C2777583451 @default.
• W1570233631 hasConcept C2778729363 @default.
• W1570233631 hasConcept C2778820342 @default.
• W1570233631 hasConcept C28328180 @default.
• W1570233631 hasConcept C2908647359 @default.
• W1570233631 hasConcept C3019892230 @default.
• W1570233631 hasConcept C502942594 @default.
• W1570233631 hasConcept C54355233 @default.
• W1570233631 hasConcept C71924100 @default.
• W1570233631 hasConcept C86803240 @default.
• W1570233631 hasConcept C99454951 @default.
• W1570233631 hasConceptScore W1570233631C10205521 @default.
• W1570233631 hasConceptScore W1570233631C121608353 @default.
• W1570233631 hasConceptScore W1570233631C126322002 @default.
• W1570233631 hasConceptScore W1570233631C142724271 @default.
• W1570233631 hasConceptScore W1570233631C143998085 @default.
• W1570233631 hasConceptScore W1570233631C2776256026 @default.
• W1570233631 hasConceptScore W1570233631C2776839831 @default.
• W1570233631 hasConceptScore W1570233631C2777583451 @default.
• W1570233631 hasConceptScore W1570233631C2778729363 @default.
• W1570233631 hasConceptScore W1570233631C2778820342 @default.
• W1570233631 hasConceptScore W1570233631C28328180 @default.
• W1570233631 hasConceptScore W1570233631C2908647359 @default.
• W1570233631 hasConceptScore W1570233631C3019892230 @default.
• W1570233631 hasConceptScore W1570233631C502942594 @default.
• W1570233631 hasConceptScore W1570233631C54355233 @default.
• W1570233631 hasConceptScore W1570233631C71924100 @default.
• W1570233631 hasConceptScore W1570233631C86803240 @default.
• W1570233631 hasConceptScore W1570233631C99454951 @default.
• W1570233631 hasIssue "10" @default.
• W1570233631 hasLocation W15702336311 @default.
• W1570233631 hasLocation W15702336312 @default.
• W1570233631 hasOpenAccess W1570233631 @default.
• W1570233631 hasPrimaryLocation W15702336311 @default.

• next